Biotron Limited is an Australian biotechnology company developing and commercializing novel therapeutics and diagnostics to address a range of significant health issues.

Biotron's current focus is on development of novel antiviral therapeutics and high-throughput screening technologies for cancer diagnosis. In addition, the Company has a number of early-stage projects targeting other indications such as cardiovascular disease.

RECENT ANNOUNCEMENTS

Quarterly Report 31 March 2009

New Issue Announcement - HCV Trial Update

Change of Director's Interest Notice

 

2008 Annual Report

BIT225-003: Phase Ib HCV Trial Information